194 related articles for article (PubMed ID: 16466923)
1. Design, synthesis, and evaluation of new type of L-amino acids containing pyridine moiety as nitric oxide synthase inhibitor.
Ijuin R; Umezawa N; Higuchi T
Bioorg Med Chem; 2006 May; 14(10):3563-70. PubMed ID: 16466923
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of 3-substituted arginine analogs as selective inhibitors of human nitric oxide synthase isozymes.
Ijuin R; Umezawa N; Nagai S; Higuchi T
Bioorg Med Chem Lett; 2005 Jun; 15(11):2881-5. PubMed ID: 15911272
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological testing of potential heme-coordinating nitric oxide synthase inhibitors.
Litzinger EA; Martásek P; Roman LJ; Silverman RB
Bioorg Med Chem; 2006 May; 14(9):3185-98. PubMed ID: 16431112
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a series of aminopiperidines as novel iNOS inhibitors.
Le Bourdonnec B; Leister LK; Ajello CA; Cassel JA; Seida PR; O'Hare H; Gu M; Chu GH; Tuthill PA; DeHaven RN; Dolle RE
Bioorg Med Chem Lett; 2008 Jan; 18(1):336-43. PubMed ID: 18024030
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of pyrido[1,2-a]pyrimidines as inhibitors of nitric oxide synthases.
Bluhm U; Boucher JL; Buss U; Clement B; Friedrich F; Girreser U; Heber D; Lam T; Lepoivre M; Rostaie-Gerylow M; Wolschendorf U
Eur J Med Chem; 2009 Jul; 44(7):2877-87. PubMed ID: 19144449
[TBL] [Abstract][Full Text] [Related]
6. Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms.
Webber RK; Metz S; Moore WM; Connor JR; Currie MG; Fok KF; Hagen TJ; Hansen DW; Jerome GM; Manning PT; Pitzele BS; Toth MV; Trivedi M; Zupec ME; Tjoeng FS
J Med Chem; 1998 Jan; 41(1):96-101. PubMed ID: 9438025
[TBL] [Abstract][Full Text] [Related]
7. Nitroaromatic amino acids as inhibitors of neuronal nitric oxide synthase.
Cowart M; Kowaluk EA; Daanen JF; Kohlhaas KL; Alexander KM; Wagenaar FL; Kerwin JF
J Med Chem; 1998 Jul; 41(14):2636-42. PubMed ID: 9651169
[TBL] [Abstract][Full Text] [Related]
8. Computer modeling of selective regions in the active site of nitric oxide synthases: implication for the design of isoform-selective inhibitors.
Ji H; Li H; Flinspach M; Poulos TL; Silverman RB
J Med Chem; 2003 Dec; 46(26):5700-11. PubMed ID: 14667223
[TBL] [Abstract][Full Text] [Related]
9. Structure and activity of NO synthase inhibitors specific to the L-arginine binding site.
Proskuryakov SY; Konoplyannikov AG; Skvortsov VG; Mandrugin AA; Fedoseev VM
Biochemistry (Mosc); 2005 Jan; 70(1):8-23. PubMed ID: 15701046
[TBL] [Abstract][Full Text] [Related]
10. The iromycins, a new family of pyridone metabolites from Streptomyces sp. I. Structure, NOS inhibitory activity, and biosynthesis.
Surup F; Wagner O; von Frieling J; Schleicher M; Oess S; Müller P; Grond S
J Org Chem; 2007 Jul; 72(14):5085-90. PubMed ID: 17564461
[TBL] [Abstract][Full Text] [Related]
11. Imidazole-containing amino acids as selective inhibitors of nitric oxide synthases.
Lee Y; Martasek P; Roman LJ; Masters BS; Silverman RB
Bioorg Med Chem; 1999 Sep; 7(9):1941-51. PubMed ID: 10530943
[TBL] [Abstract][Full Text] [Related]
12. 1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo.
Tinker AC; Beaton HG; Boughton-Smith N; Cook TR; Cooper SL; Fraser-Rae L; Hallam K; Hamley P; McInally T; Nicholls DJ; Pimm AD; Wallace AV
J Med Chem; 2003 Mar; 46(6):913-6. PubMed ID: 12620067
[TBL] [Abstract][Full Text] [Related]
13. IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine binding.
Buckley GM; Ceska TA; Fraser JL; Gowers L; Groom CR; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V
Bioorg Med Chem Lett; 2008 Jun; 18(11):3291-5. PubMed ID: 18482836
[TBL] [Abstract][Full Text] [Related]
14. Design and campaign synthesis of pyridine-based histone deacetylase inhibitors.
Andrews DM; Gibson KM; Graham MA; Matusiak ZS; Roberts CA; Stokes ES; Brady MC; Chresta CM
Bioorg Med Chem Lett; 2008 Apr; 18(8):2525-9. PubMed ID: 18378451
[TBL] [Abstract][Full Text] [Related]
15. Substituted 6-phenyl-pyridin-2-ylamines: selective and potent inhibitors of neuronal nitric oxide synthase.
Nason DM; Heck SD; Bodenstein MS; Lowe JA; Nelson RB; Liston DR; Nolan CE; Lanyon LF; Ward KM; Volkmann RA
Bioorg Med Chem Lett; 2004 Sep; 14(17):4511-4. PubMed ID: 15357982
[TBL] [Abstract][Full Text] [Related]
16. Novel 2-aminobenzothiazoles as selective neuronal nitric oxide synthase inhibitors.
Patman J; Bhardwaj N; Ramnauth J; Annedi SC; Renton P; Maddaford SP; Rakhit S; Andrews JS
Bioorg Med Chem Lett; 2007 May; 17(9):2540-4. PubMed ID: 17317165
[TBL] [Abstract][Full Text] [Related]
17. Phenylpyrrole derivatives as neural and inducible nitric oxide synthase (nNOS and iNOS) inhibitors.
López Cara LC; Camacho ME; Carrión MD; Tapias V; Gallo MA; Escames G; Acuña-Castroviejo D; Espinosa A; Entrena A
Eur J Med Chem; 2009 Jun; 44(6):2655-66. PubMed ID: 19117642
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation, and molecular docking of Ugi products containing a zinc-chelating moiety as novel inhibitors of histone deacetylases.
Grolla AA; Podestà V; Chini MG; Di Micco S; Vallario A; Genazzani AA; Canonico PL; Bifulco G; Tron GC; Sorba G; Pirali T
J Med Chem; 2009 May; 52(9):2776-85. PubMed ID: 19344175
[TBL] [Abstract][Full Text] [Related]
19. Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights.
Grädler U; Fuchss T; Ulrich WR; Boer R; Strub A; Hesslinger C; Anézo C; Diederichs K; Zaliani A
Bioorg Med Chem Lett; 2011 Jul; 21(14):4228-32. PubMed ID: 21684157
[TBL] [Abstract][Full Text] [Related]
20. Biology and chemistry of the inhibition of nitric oxide synthases by pteridine-derivatives as therapeutic agents.
Matter H; Kotsonis P
Med Res Rev; 2004 Sep; 24(5):662-84. PubMed ID: 15224385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
